VitaNova Life Sciences Corp (VNOV)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jul 31, 2026 · updated Oct 29, 2026
as filed in 10-Q FY2026, period ended Jul 31, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jul 31, 2026, VitaNova Life Sciences Corp reported revenue of $321,576, net income of -$123,101, and total assets of $2.2M. Every figure below is taken directly from VitaNova Life Sciences Corp's SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2017–FY2026 · as reported
- FY2017 revenue
- $0
- FY2026 revenue
- $3.0M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2026 | $3.0M | -$37,304 |
| FY2025 | $2.7M | $850,746 |
| FY2024 | $570,694 | $140,865 |
| FY2023 | $38,000 | -$24,227 |
| FY2022 | $120,000 | $139,682 |
| FY2021 | $0 | -$52,094 |
| FY2020 | $0 | -$72,334 |
| FY2019 | $0 | -$106,167 |
| FY2018 | $0 | -$1,595 |
| FY2017 | $0 | -$7,175 |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 10-Q | Sep 14, 2026 | on EDGAR ↗ |
| 10-K | Jul 29, 2026 | on EDGAR ↗ |
| 8-K | Mar 18, 2026 | on EDGAR ↗ |
| 10-Q | Mar 16, 2026 | on EDGAR ↗ |
| 8-K | Feb 25, 2026 | on EDGAR ↗ |
| 8-K | Jan 27, 2026 | on EDGAR ↗ |
| 8-K | Jan 13, 2026 | on EDGAR ↗ |
| 10-Q | Dec 15, 2025 | on EDGAR ↗ |
| 8-K | Oct 7, 2025 | on EDGAR ↗ |
| 10-Q | Sep 12, 2025 | on EDGAR ↗ |
Balance Sheet
as of Jul 31, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jul 31, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Jul 31, 2026
Restatement history
Point-in-time3 of 194 annual fact-keys were materially restated between filings: what VitaNova Life Sciences Corp first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches VNOV’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/VNOV
MCP tool:
get_sec_fundamentals ticker=VNOV - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/VNOV/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=VNOV as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/VNOV/history
MCP tool:
get_fundamentals_history ticker=VNOV - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/VNOV
MCP tool:
get_financial_health ticker=VNOV
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.